BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33001861)

  • 21. Abnormal expression and processing of uromodulin in Fabry disease reflects tubular cell storage alteration and is reversible by enzyme replacement therapy.
    Vylet'al P; Hůlková H; Zivná M; Berná L; Novák P; Elleder M; Kmoch S
    J Inherit Metab Dis; 2008 Aug; 31(4):508-17. PubMed ID: 18651238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepsin-mediated Processing of Uromodulin is Crucial for Salt-sensitivity and Thick Ascending Limb Homeostasis.
    Olinger E; Lake J; Sheehan S; Schiano G; Takata T; Tokonami N; Debaix H; Consolato F; Rampoldi L; Korstanje R; Devuyst O
    Sci Rep; 2019 Aug; 9(1):12287. PubMed ID: 31444371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Uromodulin Mutation Drives Autoimmunity and Kidney Mononuclear Phagocyte Endoplasmic Reticulum Stress.
    Plotkin M; O'Brien CA; Goellner J; Williams J; Carter W; Sharma S; Stone A
    Am J Pathol; 2020 Dec; 190(12):2436-2452. PubMed ID: 32926855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type of uromodulin mutation and allelic status influence onset and severity of uromodulin-associated kidney disease in mice.
    Kemter E; Prueckl P; Sklenak S; Rathkolb B; Habermann FA; Hans W; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Wolf E; Aigner B; Wanke R
    Hum Mol Genet; 2013 Oct; 22(20):4148-63. PubMed ID: 23748428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uromodulin deficiency alters tubular injury and interstitial inflammation but not fibrosis in experimental obstructive nephropathy.
    Maydan O; McDade PG; Liu Y; Wu XR; Matsell DG; Eddy AA
    Physiol Rep; 2018 Mar; 6(6):e13654. PubMed ID: 29595914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salt stress in the renal tubules is linked to TAL-specific expression of uromodulin and an upregulation of heat shock genes.
    Graham LA; Aman A; Campbell DD; Augley J; Graham D; McBride MW; Fraser NJ; Ferreri NR; Dominiczak AF; Padmanabhan S
    Physiol Genomics; 2018 Nov; 50(11):964-972. PubMed ID: 30216136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mosaic loss of non-muscle myosin IIA and IIB is sufficient to induce mammary epithelial proliferation.
    Nguyen-Ngoc KV; Silvestri VL; Georgess D; Fairchild AN; Ewald AJ
    J Cell Sci; 2017 Oct; 130(19):3213-3221. PubMed ID: 28821574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutation: A Two-Case Report and Literature Review.
    Liang D; Liang S; Zhang M; Gao E; Zhang Z; Jin Y; Xu F; Zeng C
    Nephron; 2019; 143(4):282-287. PubMed ID: 31422399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Mec17-Myosin II Effector Axis Coordinates Microtubule Acetylation and Actin Dynamics to Control Primary Cilium Biogenesis.
    Rao Y; Hao R; Wang B; Yao TP
    PLoS One; 2014; 9(12):e114087. PubMed ID: 25494100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uromodulin regulates renal magnesium homeostasis through the ion channel transient receptor potential melastatin 6 (TRPM6).
    Nie M; Bal MS; Liu J; Yang Z; Rivera C; Wu XR; Hoenderop JGJ; Bindels RJM; Marciano DK; Wolf MTF
    J Biol Chem; 2018 Oct; 293(42):16488-16502. PubMed ID: 30139743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uromodulin and chronic kidney disease.
    Lhotta K
    Kidney Blood Press Res; 2010; 33(5):393-8. PubMed ID: 20948228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uromodulin-related autosomal-dominant tubulointerstitial kidney disease-pathogenetic insights based on a case.
    Reindl J; Gröne HJ; Wolf G; Busch M
    Clin Kidney J; 2019 Apr; 12(2):172-179. PubMed ID: 30976393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonmuscle myosin IIB regulates epicardial integrity and epicardium-derived mesenchymal cell maturation.
    Ma X; Sung DC; Yang Y; Wakabayashi Y; Adelstein RS
    J Cell Sci; 2017 Aug; 130(16):2696-2706. PubMed ID: 28687623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allelic effects on uromodulin aggregates drive autosomal dominant tubulointerstitial kidney disease.
    Schiano G; Lake J; Mariniello M; Schaeffer C; Harvent M; Rampoldi L; Olinger E; Devuyst O
    EMBO Mol Med; 2023 Dec; 15(12):e18242. PubMed ID: 37885358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiscale analysis of single and double maternal-zygotic
    Schliffka MF; Tortorelli AF; Özgüç Ö; de Plater L; Polzer O; Pelzer D; Maître JL
    Elife; 2021 Apr; 10():. PubMed ID: 33871354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glomerular MYH9 expression is reduced by HIV-1.
    Hays T; D'Agati VD; Garellek JA; Warren T; Trubin ME; Hyink DP; He JC; Klotman PE
    AIDS; 2012 Apr; 26(7):797-803. PubMed ID: 22313957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoplasmic reticulum stress and monogenic kidney diseases in precision nephrology.
    Park SJ; Kim Y; Chen YM
    Pediatr Nephrol; 2019 Sep; 34(9):1493-1500. PubMed ID: 30099615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The intrinsic prostaglandin E2-EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice.
    Nakagawa N; Yuhki K; Kawabe J; Fujino T; Takahata O; Kabara M; Abe K; Kojima F; Kashiwagi H; Hasebe N; Kikuchi K; Sugimoto Y; Narumiya S; Ushikubi F
    Kidney Int; 2012 Jul; 82(2):158-71. PubMed ID: 22513820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrabright plasmonic fluor nanolabel-enabled detection of a urinary ER stress biomarker in autosomal dominant tubulointerstitial kidney disease.
    Kim Y; Wang Z; Li C; Kidd K; Wang Y; Johnson BG; Kmoch S; Morrissey JJ; Bleyer AJ; Duffield JS; Singamaneni S; Chen YM
    Am J Physiol Renal Physiol; 2021 Aug; 321(2):F236-F244. PubMed ID: 34251273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A.
    Zhang Y; Conti MA; Malide D; Dong F; Wang A; Shmist YA; Liu C; Zerfas P; Daniels MP; Chan CC; Kozin E; Kachar B; Kelley MJ; Kopp JB; Adelstein RS
    Blood; 2012 Jan; 119(1):238-50. PubMed ID: 21908426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.